Insider Transactions Reported by 22 Insiders of Terns Pharmaceuticals, Inc.

Symbol: TERN on Nasdaq
Location: Foster City, CA

Key facts

TERN - Terns Pharmaceuticals, Inc. has 22 insiders with reported activity on this page.
Net insider value flow over the last year: -$6,879,577.
Recent transaction rows are available for direct filing-level review.

Change

Buy value: $186,595; sell value: $7,066,172.
Net share flow: -149,354.

Research use

This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Net insider flow leans to selling over the last 12 months. Net value: -$6,879,577.

Buys

$186,595

Shares: 48,314

Insiders: 2

Sells

$7,066,172

Shares: 197,668

Insiders: 3

Net

-$6,879,577

Shares: -149,354

Insiders: -1

Window (months)	Buy shares	Sell shares	Buy $	Sell $	Net $
0-3	0	15,525	$0	$730,801	-$730,801
3-6	0	155,826	$0	$5,882,964	-$5,882,964
6-9	0	25,464	$0	$448,767	-$448,767
9-12	48,314	853	$186,595	$3,640	+$182,956

Terns Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Valuation	Report Date
Vivo Opportunity, LLC	10%+ Owner	$38,671,440			Filing P/S	01 Apr 2024
Carl L. Gordon	Director, 10%+ Owner	$7,556,350			Filing P/S	15 Jul 2024
ORBIMED ADVISORS LLC	Director, 10%+ Owner	$7,556,350			Filing P/S	15 Jul 2024
Hongbo Lu	Director	$4,999,995			Filing P/S	11 Jun 2025
LAV Biosciences Fund V, L.P.	10%+ Owner	$2,002,500			Mixed	23 Nov 2022
David Eric Strauss	Principal Accounting Officer	$519,682			Mixed	01 Feb 2025
Mark J. Vignola	Chief Financial Officer	$433,210			Filing P/S	02 Jan 2025
Seokho Bryan Yoon	COO and General Counsel	$408,214			Filing P/S	31 May 2024
Erin Quirk	President, Head of R&D	$283,500			Mixed	23 Jan 2024
Senthil Vel Sundaram	Chief Executive Officer, Director	$36,931			Mixed	31 May 2023
Melita Sun Jung	Chief Business Officer	$11,498			Filing P/S	30 Jan 2025
Jill M. Quigley	Director	$0	-$441,360	-100%	Mixed	05 May 2026
Amy L. Burroughs	Chief Executive Officer, Director	$0	-$6,429,290	-100%	Mixed	05 May 2026
Emil Kuriakose	Chief Medical Officer	$0	-$105,292	-100%	Mixed	05 May 2026
Andrew Gengos	Chief Financial Officer	$0	+$96,366		Mixed	05 May 2026
Radhika Tripuraneni	Director				Mixed	05 May 2026
Heather D. Turner	Director				Mixed	05 May 2026
Robert Azelby	Director				Mixed	05 May 2026
David A. Fellows	Director				Mixed	05 May 2026
Jeffrey B. Kindler	Director				Mixed	05 May 2026
Ann Elizabeth Taylor	Director				Mixed	01 Jul 2024
Kerry Strong Russell	Chief Medical Officer				Mixed	01 Jul 2022

Top shareholders of Terns Pharmaceuticals, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock, Inc.	13F 13D/G	Company	6.8% from 13D/G	9,569,585	$504,508,547	—	31 Mar 2026	13F 13D/G
MORGAN STANLEY	13F 13D/G	Company	5.6% from 13D/G	6,449,140	$339,998,702	—	31 Mar 2026	13F 13D/G
Schonfeld Strategic Advisors LLC	13D/G 13F	Company	4.9%	4,305,204	$12,571,196	-$2,713,568	31 Mar 2025	13D/G 13F
ORBIMED ADVISORS LLC	13D/G 3/4/5	Director, 10%+ Owner	4.8%	4,240,068	$31,842,911	$0	03 Nov 2025	13D/G 3/4/5
CITADEL ADVISORS LLC	13F 13D/G	Company · Kenneth Griffin	4.1% from 13D/G	3,218,810	$169,695,663	—	31 Mar 2026	13F 13D/G
Deep Track Capital, LP	13D/G 13F	Company	3%	3,150,000	$111,762,000	-$154,160,600	31 Dec 2025	13D/G 13F
Vivo Opportunity Fund Holdings, L.P.	13D/G	—	2.5%	2,700,615	$95,817,820	$0	31 Jan 2025	13D/G
Adage Capital Management, L.P.	13D/G	—	1.8%	2,124,817	$111,829,119	-$180,267,381	31 Mar 2026	13D/G
Commodore Capital LP	13D/G	—	1.4%	1,475,000	$52,333,000	-$149,903,000	31 Dec 2025	13D/G
Soleus Capital Master Fund, L.P.	13D/G	—	0.2%	212,710	$7,546,951	-$281,348,949	31 Dec 2025	13D/G
Avoro Capital Advisors LLC	13F	Company	4.9%	5,695,000	$300,240,400	—	31 Mar 2026	13F
VANGUARD CAPITAL MANAGEMENT LLC	13F	Company	3.8%	4,355,482	$229,621,011	—	31 Mar 2026	13F
Holocene Advisors, LP	13F	Company	3.6%	4,115,828	$216,986,452	—	31 Mar 2026	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	2.6%	3,011,558	$158,769,338	—	31 Mar 2026	13F
HBK INVESTMENTS L P	13F	Company	2.6%	2,950,000	$155,524,000	—	31 Mar 2026	13F
JPMORGAN CHASE & CO	13F	Company	2.5%	2,869,728	$151,751,216	—	31 Mar 2026	13F
LORD, ABBETT & CO. LLC	13F	Company	2.4%	2,812,938	$148,298,000	—	31 Mar 2026	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	2.4%	2,779,445	$146,532,340	—	31 Mar 2026	13F
FRANKLIN RESOURCES INC	13F	Company	2.1%	2,409,019	$127,003,475	—	31 Mar 2026	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	2%	2,316,544	$122,150,819	—	31 Mar 2026	13F
GLAZER CAPITAL, LLC	13F	Company	2%	2,295,498	$121,019,000	—	31 Mar 2026	13F
Paradigm Biocapital Advisors LP	13F	Company	1.9%	2,216,499	$116,853,827	—	31 Mar 2026	13F
Nearwater Capital Markets, Ltd	13F	Company	1.9%	2,150,400	$113,369,088	—	31 Mar 2026	13F
STATE STREET CORP	13F	Company	1.9%	2,139,662	$112,802,981	—	31 Mar 2026	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1.8%	2,124,817	$112,020,352	—	31 Mar 2026	13F
CAPITOLIS LIQUID GLOBAL MARKETS LLC	13F	Company	1.7%	1,975,800	$104,164,176	—	31 Mar 2026	13F
ACORN CAPITAL ADVISORS, LLC	13F	Company	1.5%	1,746,264	$92,063,038	—	31 Mar 2026	13F
Pictet Asset Management Holding SA	13F	Company	1.4%	1,655,575	$87,290,178	—	31 Mar 2026	13F
Logos Global Management LP	13F	Company	1.3%	1,500,000	$79,080,000	—	31 Mar 2026	13F
JANUS HENDERSON GROUP PLC	13F	Company	1.3%	1,470,057	$77,511,671	—	31 Mar 2026	13F
Ikarian Capital, LLC	13F	Company	1.3%	1,456,378	$76,780,248	—	31 Mar 2026	13F
Capital International Investors	13F	Company	1.2%	1,424,504	$75,099,851	—	31 Mar 2026	13F
Vivo Capital, LLC	13F	Company	1.2%	1,334,418	$70,350,517	—	31 Mar 2026	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.1%	1,247,845	$65,786,838	—	31 Mar 2026	13F
UBS Group AG	13F	Company	1.1%	1,228,726	$64,778,435	—	31 Mar 2026	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.96%	1,106,961	$58,358,984	—	31 Mar 2026	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.89%	1,032,679	$41,720,232	—	31 Mar 2026	13F
WHITEBOX ADVISORS LLC	13F	Company	0.87%	1,000,001	$52,720,053	—	31 Mar 2026	13F
Vestal Point Capital, LP	13F	Company	0.87%	1,000,000	$52,720,000	—	31 Mar 2026	13F
MARSHALL WACE, LLP	13F	Company	0.8%	927,600	$48,903,074	—	31 Mar 2026	13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	0.8%	924,562	$48,742,909	—	31 Mar 2026	13F
ADAR1 Capital Management, LLC	13F	Company	0.79%	914,699	$48,222,931	—	31 Mar 2026	13F
NEXPOINT ASSET MANAGEMENT, L.P.	13F	Company	0.78%	904,200	$47,669,424	—	31 Mar 2026	13F
First Trust Capital Management L.P.	13F	Company	0.78%	904,161	$47,667,368	—	31 Mar 2026	13F
Fort Baker Capital Management LP	13F	Company	0.71%	822,000	$43,335,840	—	31 Mar 2026	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.7%	811,636	$42,789,450	—	31 Mar 2026	13F
NORTHERN TRUST CORP	13F	Company	0.7%	805,236	$42,452,042	—	31 Mar 2026	13F
Verition Fund Management LLC	13F	Company	0.69%	802,293	$42,296,887	—	31 Mar 2026	13F
TORONTO DOMINION BANK	13F	Company	0.68%	781,800	$41,216,496	—	31 Mar 2026	13F
Nuveen, LLC	13F	Company	0.67%	772,592	$40,731,050	—	31 Mar 2026	13F

Recent Insider Transactions by Companies or Individuals for Terns Pharmaceuticals, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership
Robert Azelby	TERN	Stock Option (Right to Buy)	Disposed to Issuer	-100%			-91,697	0	05 May 2026	Direct
Heather D. Turner	TERN	Stock Option (Right to Buy)	Disposed to Issuer	-100%			-110,697	0	05 May 2026	Direct
Radhika Tripuraneni	TERN	Stock Option (Right to Buy)	Disposed to Issuer	-100%			-158,030	0	05 May 2026	Direct
Jill M. Quigley	TERN	Stock Option (Right to Buy)	Disposed to Issuer	-100%			-115,309	0	05 May 2026	Direct
Jeffrey B. Kindler	TERN	Stock Option (Right to Buy)	Disposed to Issuer	-100%			-144,505	0	05 May 2026	Direct
David A. Fellows	TERN	Stock Option (Right to Buy)	Disposed to Issuer	-100%			-157,136	0	05 May 2026	Direct
Emil Kuriakose	TERN	Common Stock	Disposed to Issuer	-100%			-81,953	0	05 May 2026	Direct
Emil Kuriakose	TERN	Common Stock	Disposition pursuant to a tender of shares in a change of control transaction	-100%			-24,562	0	05 May 2026	Direct
Emil Kuriakose	TERN	Stock Option (Right to Buy)	Disposed to Issuer	-100%			-1,115,000	0	05 May 2026	Direct
Andrew Gengos	TERN	Common Stock	Disposed to Issuer	-100%			-68,750	0	05 May 2026	Direct
Andrew Gengos	TERN	Common Stock	Disposition pursuant to a tender of shares in a change of control transaction	-100%			-40,503	0	05 May 2026	Direct
Andrew Gengos	TERN	Stock Option (Right to Buy)	Disposed to Issuer	-100%			-887,500	0	05 May 2026	Direct
Amy L. Burroughs	TERN	Common Stock	Disposed to Issuer	-100%			-150,000	0	05 May 2026	Direct
Amy L. Burroughs	TERN	Common Stock	Disposition pursuant to a tender of shares in a change of control transaction	-100%			-8,319	0	05 May 2026	Trust
Amy L. Burroughs	TERN	Common Stock	Disposition pursuant to a tender of shares in a change of control transaction	-100%			-146,614	0	05 May 2026	Direct
Amy L. Burroughs	TERN	Stock Option (Right to Buy)	Disposed to Issuer	-100%			-2,505,534	0	05 May 2026	Direct
Emil Kuriakose	TERN	Common Stock	Sale	-0.88%	$49,693	$52.75	-942	105,673	01 Apr 2026	Direct
Amy L. Burroughs	TERN	Common Stock	Sale	-4.8%	$681,108	$46.71	-14,583	288,976	16 Mar 2026	Direct
Amy L. Burroughs	TERN	Common Stock	Options Exercise	5.05%			14,583	303,559	16 Mar 2026	Direct
Amy L. Burroughs	TERN	Stock Option (Right to Buy)	Options Exercise	-1.5%			-14,583	955,534	16 Mar 2026	Direct
Amy L. Burroughs	TERN	Common Stock	Sale	-4.8%	$571,579	$39.19	-14,583	288,976	17 Feb 2026	Direct
Amy L. Burroughs	TERN	Common Stock	Options Exercise	5.05%			14,583	303,559	17 Feb 2026	Direct
Amy L. Burroughs	TERN	Stock Option (Right to Buy)	Options Exercise	-1.48%			-14,583	970,117	17 Feb 2026	Direct
Jill M. Quigley	TERN	Stock Option (Right to Buy)	Award				1,697	1,697	01 Feb 2026	Direct
Radhika Tripuraneni	TERN	Stock Option (Right to Buy)	Award				1,697	1,697	01 Feb 2026	Direct
Robert Azelby	TERN	Stock Option (Right to Buy)	Award				1,697	1,697	01 Feb 2026	Direct
Heather D. Turner	TERN	Stock Option (Right to Buy)	Award				1,697	1,697	01 Feb 2026	Direct
Jeffrey B. Kindler	TERN	Stock Option (Right to Buy)	Award				1,697	1,697	01 Feb 2026	Direct
David A. Fellows	TERN	Stock Option (Right to Buy)	Award				2,828	2,828	01 Feb 2026	Direct
Amy L. Burroughs	TERN	Common Stock	Sale	-19.2%	$2,548,603	$37.07	-68,749	288,976	15 Jan 2026	Direct
Amy L. Burroughs	TERN	Common Stock	Options Exercise	23.8%			68,749	357,725	15 Jan 2026	Direct
Amy L. Burroughs	TERN	Stock Option (Right to Buy)	Options Exercise	-6.53%			-68,749	984,700	15 Jan 2026	Direct
Emil Kuriakose	TERN	Common Stock	Award	111.7%			56,250	106,615	14 Jan 2026	Direct
Emil Kuriakose	TERN	Stock Option (Right to Buy)	Award				112,500	112,500	14 Jan 2026	Direct
Andrew Gengos	TERN	Common Stock	Award	208.1%			68,750	101,788	14 Jan 2026	Direct
Andrew Gengos	TERN	Stock Option (Right to Buy)	Award				137,500	137,500	14 Jan 2026	Direct
Amy L. Burroughs	TERN	Common Stock	Award	107.9%			150,000	288,976	14 Jan 2026	Direct
Amy L. Burroughs	TERN	Stock Option (Right to Buy)	Award				300,000	300,000	14 Jan 2026	Direct
Amy L. Burroughs	TERN	Common Stock	Sale	-33.9%	$2,718,230	$38.10	-71,339	138,976	05 Jan 2026	Direct
Amy L. Burroughs	TERN	Common Stock	Options Exercise	248.7%			150,000	210,315	05 Jan 2026	Direct
Amy L. Burroughs	TERN	Restricted Stock Unit	Options Exercise	-100%			-150,000	0	05 Jan 2026	Direct
Amy L. Burroughs	TERN	Common Stock	Options Exercise	55.6%			21,551	60,315	02 Jan 2026	Direct
Amy L. Burroughs	TERN	Stock Option (Right to Buy)	Options Exercise	-2%			-21,551	1,053,449	02 Jan 2026	Direct
Emil Kuriakose	TERN	Common Stock	Sale	-2.24%	$44,552	$38.57	-1,155	50,365	02 Jan 2026	Direct
Jill M. Quigley	TERN	Common Stock	Sale	-100%	$441,360	$18.00	-24,520	0	04 Nov 2025	Direct
Jill M. Quigley	TERN	Common Stock	Options Exercise				24,520	24,520	04 Nov 2025	Direct
Jill M. Quigley	TERN	Stock Option (Right to Buy)	Options Exercise	-86.1%			-24,520	3,955	04 Nov 2025	Direct
Emil Kuriakose	TERN	Common Stock	Sale	-1.8%	$7,407	$7.85	-944	51,520	01 Oct 2025	Direct
Emil Kuriakose	TERN	Common Stock	Sale	-1.6%	$3,640	$4.27	-853	52,464	01 Jul 2025	Direct
Andrew Gengos	TERN	Common Stock	Purchase	66.7%	$39,283	$3.93	10,000	25,000	27 Jun 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.